Healthcare & Life Sciences
InterMune
United Statesintermune.com
InterMune is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About InterMune
InterMune is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
InterMune develops biopharmaceutical therapies targeting rare and serious diseases, focused primarily on pulmonary and fibrotic conditions such as pulmonary fibrosis.
Explore InterMune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.